image image image
image UASOM Div. Continuing Medical Education Alabama Practice-Based CME Network AQAF image
image image image
 
Home
CME
Courses
Geriatric-Focused Courses
Research
Online Resources
Literature Archives
Patient Edu. Resources
Other Resources
Networking
Forum
Membership Services
Member Registration
Literature Search Request
Medical Letter
Featured News
Membership Profile
EHR Corner
Glossary of Terms
Courses
Home > CME > Courses
Outpatient Evaluation and Management of Atrial Fibrillation, Part I

Certified for 1 AMA PRA Category 1 Credit

Co-Sponsored by the University of Alabama School of Medicine
Division of Continuing Medical Education and
Alabama Quality Assurance Foundation

Release Date: February 5, 2007
Expiration Date: February 5, 2010
TARGET AUDIENCE:
Primary care physicians

OBJECTIVES:
Upon completion of this CME activity, physicians and other healthcare professionals should be able to:
  • Recognize that hypertension remains a large public health issue in part because of under diagnosis and poor control.
  • Understand lifestyle and pharmacologic treatment approaches for control of hypertension.
  • Appreciate controversies regarding initial drug choices for treating hypertension.
Top of Page

SOURCE:
FACULTY:

Carlos Estrada, MD
Associate Professor of Medicine
University of Alabama at Birmingham

Top of Page
 
DISCLOSURE:
The faculty discloses grants/research support from the NIH: NHLBI and honoraria from ACP Medicine - Institute for Healthcare Education.

Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.

CME PARTICIPATION:
To participate in this online course for CME credit, please review the objectives before beginning the program. Complete the course and the self-assessment test before February 5, 2010 to receive CME credit. Your certificate will then be available online. This process should take approximately 1 hour.

ACCREDITATION:

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

Top of Page

DISCLAIMER: 
Dosages, indications, and methods of use of any drug referred to in this publication may reflect the clinical experience of the authors, clinical literature, or other clinical resources. Therefore, please see the full prescribing information before using any product mentioned. UAB is an equal opportunity/affirmative action institution.

INTRODUCTION:

This online course represents the first part of a series of two courses on the evaluation and management of Atrial Fibrillation.

Atrial fibrillation (AF) is a supraventricular arrhythmia characterized by uncoordinated atrial activation. The p wave is absent on EKG and the rhythm on the physical exam is usually irregular-irregular. The prevalence of atrial fibrillation increases with age. In apidemiological studies, the mortality is increased in patients with AF.[1]

Atrial fibrillation lasting more than 30 seconds can be:

  • Paroxysmal (recurrent episodes lasting 1-7 days)
  • Persistent (episodes lasting > 7 days, can be terminated by cardioversion)
  • Recurrent (>= 2 episodes)
  • Permanent (lasts > 1 year)
  • "Lone" (age < 60 years, no cardiac or pulmonary disease)

The above categories are not mutually exclusive, i.e.: a patient may have more than one category.[1]

The level of evidence indicated in the answers were reported in the ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation (highest to lowest):

  • Level of Evidence A: Data from multiple randomized cliical trials or meta-analyses.
  • Level of Evidence B: Data from a single randomized trial, or non-randomized studies.
  • Level of Evidence C: Only consensus opinion of experts, case studies, or standard-of-care.

Similarly, recommendations were classified[1] as:

  • Class I: Evidence available and/or general agreement that approach is beneficial.
  • Class II: Conflicting evidence and/or lack of agreement that approach is beneficial.
  • Class III: Evidence available and/or general agreement that approach is NOT beneficial.
Top of Page

Case 1:

A 46-year-old woman sees you because of anxiety. Over the past 2-3 months she feel anxious all of the time, has lost 10 lbs (unintentional) and has experienced palpitations. She is otherwise healthy and takes no medications. She is married and has 2 young children. She does not smoke.

On physical examination, her blood pressure if 144/80mmHg, her pulse if 124/min (irregular-irregular), and her temperature is normal. She has a mild tremor, mild exophtalmus, terse skin, mild pre-tibial non-pitting edema, and brisk deep tendon reflexes. She also has a mildly enlarged non-tender thyroid with a bruit. Her cardiovascular exam shows normal neck veins, a non-enlarged heart, normal heart sounds and a soft flow murmur. Her electrocardiogram shows atrial fibrillation.

Top of Page

Case 1, Question 1 of 4

1. Which of the following studies would define the etiology of atrial fibrillation in this patient?

A. Chest X-Ray
B. Echocardiogram
C. Thyroid function studies
D. Urinary toxicology screen


Top of Page


 
|
|
|
|
| |
image image image
Copyright © 2006 University of Alabama School of Medicine - UAB. All rights reserved.